116 related articles for article (PubMed ID: 8017295)
1. Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarction (analysis of four German multicenter studies).
Vogt A; von Essen R; Tebbe U; Feuerer W; Appel KF; Niederer W; Neuhaus KL
Am J Cardiol; 1994 Jul; 74(1):1-4. PubMed ID: 8017295
[TBL] [Abstract][Full Text] [Related]
2. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
[TBL] [Abstract][Full Text] [Related]
3. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
Zarich SW; Kowalchuk GJ; Weaver WD; Loscalzo J; Sassower M; Manzo K; Byrnes C; Muller JE; Gurewich V
J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437
[TBL] [Abstract][Full Text] [Related]
4. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies.
Vogt A; von Essen R; Tebbe U; Feuerer W; Appel KF; Neuhaus KL
J Am Coll Cardiol; 1993 May; 21(6):1391-5. PubMed ID: 8473646
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
[TBL] [Abstract][Full Text] [Related]
6. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G
J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436
[TBL] [Abstract][Full Text] [Related]
7. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK
Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648
[TBL] [Abstract][Full Text] [Related]
8. Angiographically assessed coronary arterial patency and reocclusion in patients with acute myocardial infarction treated with anistreplase: results of the anistreplase reocclusion multicenter study (ARMS).
Relik-van Wely L; Visser RF; van der Pol JM; Bartholomeus I; Couvée JE; Drost H; Vet AJ; Klomps HC; van Ekelen WA; van den Berg F
Am J Cardiol; 1991 Aug; 68(4):296-300. PubMed ID: 1858670
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis in acute myocardial infarction.
Holmberg SR
Br J Hosp Med; 1992 Apr 15-May 5; 47(8):572-6, 578-80. PubMed ID: 1591557
[TBL] [Abstract][Full Text] [Related]
10. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty.
Juliard JM; Himbert D; Cristofini P; Desportes JC; Magne M; Golmard JL; Aubry P; Benamer H; Boccara A; Karrillon GJ; Steg PG
Am J Cardiol; 1999 Feb; 83(3):305-10. PubMed ID: 10072213
[TBL] [Abstract][Full Text] [Related]
11. Patency trials with reteplase (r-PA): what do they tell us?
Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
[TBL] [Abstract][Full Text] [Related]
12. TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysis.
Barbagelata NA; Granger CB; Oqueli E; Suárez LD; Borruel M; Topol EJ; Califf RM
Am Heart J; 1997 Mar; 133(3):273-82. PubMed ID: 9060794
[TBL] [Abstract][Full Text] [Related]
13. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction.
Karagounis L; Sorensen SG; Menlove RL; Moreno F; Anderson JL
J Am Coll Cardiol; 1992 Jan; 19(1):1-10. PubMed ID: 1729317
[TBL] [Abstract][Full Text] [Related]
14. HBW 023 (recombinant hirudin) for the acceleration of thrombolysis and prevention of coronary reocclusion in acute myocardial infarction: results of a dose-finding study (HIT-II) by the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte.
von Essen R; Zeymer U; Tebbe U; Jessel A; Kwasny H; Mateblowski M; Niederer W; Wagner J; Mäurer W; von Leitner ER; Haerten K; Roth M; Neuhaus KL
Coron Artery Dis; 1998; 9(5):265-72. PubMed ID: 9710686
[TBL] [Abstract][Full Text] [Related]
15. Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.
Diefenbach C; Erbel R; Pop T; Mathey D; Schofer J; Hamm C; Ostermann H; Schmitz-Hübner U; Bleifeld W; Meyer J
Am J Cardiol; 1988 May; 61(13):966-70. PubMed ID: 2452563
[TBL] [Abstract][Full Text] [Related]
16. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.
Anderson JL; Karagounis LA; Becker LC; Sorensen SG; Menlove RL
Circulation; 1993 Jun; 87(6):1829-39. PubMed ID: 8504495
[TBL] [Abstract][Full Text] [Related]
17. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
[TBL] [Abstract][Full Text] [Related]
18. Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
Gibson CM; Cannon CP; Piana RN; Breall JA; Sharaf B; Flatley M; Alexander B; Diver DJ; McCabe CH; Flaker GC
J Am Coll Cardiol; 1995 Mar; 25(3):582-9. PubMed ID: 7860900
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy reduces the incidence of left ventricular thrombus after anterior myocardial infarction. Relationship to vessel patency and infarct size.
Pizzetti G; Belotti G; Margonato A; Carlino M; Gerosa S; Carandente O; Chierchia SL
Eur Heart J; 1996 Mar; 17(3):421-8. PubMed ID: 8737217
[TBL] [Abstract][Full Text] [Related]
20. [Thrombolytic therapy in acute myocardial infarct].
Bode C; Baumann H; von Hodenberg E; Kübler W
Med Klin (Munich); 1992 Feb; 87(2):64-9. PubMed ID: 1542285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
